Literature DB >> 24105339

Concern and risk perception of osteoporosis and fracture among post-menopausal Australian women: results from the Global Longitudinal Study of Osteoporosis in Women (GLOW) cohort.

A L Barcenilla-Wong1, J S Chen, L M March.   

Abstract

PURPOSE: The purpose of this study is to identify factors associated with concern and perception of risks of osteoporosis and osteoporotic fractures and determine whether bone mineral density (BMD) testing influenced concern and risk perception.
METHODS: Study subjects (n = 1,082, age 55-94 years) were female Australian participants of the Global Longitudinal Study of Osteoporosis in Women (GLOW). Self-administered questionnaires were sent annually from 2007 to 2010. Study outcomes included 'concern about osteoporosis', 'perception of getting osteoporosis' and 'perception of fracture risk' compared to similar aged women. The closest post-BMD testing or baseline questionnaires were used for women with and without BMD testing, respectively. Multinomial logistic regression was used for the analysis.
RESULTS: BMD testing, prior fracture after age 45, younger age and lower self-reported general health were significantly associated with being 'very' or 'somewhat concerned' about osteoporosis and having a 'much higher' or 'little higher' risk perception of osteoporosis and fractures. A poorer BMD result was associated with higher concern and higher risk perceptions. The presence of comorbidities, having ≥2 falls in the preceding year and maternal osteoporosis were associated with higher concern. Maternal osteoporosis, presence of comorbidities, weight loss of ≥5 kg in the preceding year and low body mass index were associated with higher perceptions of osteoporosis risk.
CONCLUSION: Women's concern and risk perception of osteoporosis and osteoporotic fractures were reasonably well founded. However, increasing age, height loss, smoking and drinking were not associated with concern and perception despite being known osteoporosis risk factors. These factors should be considered in planning for education and awareness raising programmes.

Entities:  

Mesh:

Year:  2013        PMID: 24105339     DOI: 10.1007/s11657-013-0155-y

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  7 in total

1.  The Impact of Fracture Incidence on Health Related Quality of Life among Community-Based Postmenopausal Women.

Authors:  A L Barcenilla-Wong; J S Chen; M J Cross; L M March
Journal:  J Osteoporos       Date:  2015-07-30

2.  Prevalence and factors associated with low bone mineral density in Saudi women: a community based survey.

Authors:  Aljohara M AlQuaiz; Ambreen Kazi; Salwa Tayel; Shaffi Ahamed Shaikh; Abdullah Al-Sharif; Saleh Othman; Fawzia Habib; Mona Fouda; Riad Sulaimani
Journal:  BMC Musculoskelet Disord       Date:  2014-01-08       Impact factor: 2.362

3.  Concern and risk perception: effects on osteoprotective behaviour.

Authors:  A L Barcenilla-Wong; J S Chen; L M March
Journal:  J Osteoporos       Date:  2014-09-08

4.  A Rehabilitation-Based Multidisciplinary Care Model Reduces Hip Fracture Mortality in Older Adults.

Authors:  Chun-Feng Huang; Po-Jung Pan; Yi-Hung Chiang; Shung-Haur Yang
Journal:  J Multidiscip Healthc       Date:  2021-09-29

5.  An assessment of patients' knowledge of osteoporosis in Qatar: A pilot study.

Authors:  Samer Hammoudeh; Magdi Hassan Abdelrahman; Prem Chandra; Mohammed Hammoudeh
Journal:  Qatar Med J       Date:  2015-12-31

6.  Factors related with osteoporosis treatment in postmenopausal women.

Authors:  Lia Mara Montagner Rossi; Rafaela Martinez Copes; Leo Canterle Dal Osto; Clovis Flores; Fábio Vasconcellos Comim; Melissa Orlandin Premaor
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

7.  Reduced Circulating Levels of miR-491-5p and miR-485-3p Are Associated with the Occurrence of Vertebral Fractures in Postmenopausal Women with Osteoporosis.

Authors:  Jixi Xu; Mingbo Li; Wei Pei; Jinyong Ding; Yueran Pan; Huifeng Peng; Shiman Lin; Yanbo Huang
Journal:  Genet Res (Camb)       Date:  2022-03-07       Impact factor: 1.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.